JPMorgan Chase & Co. set a €117.00 ($125.81) price target on SAP (ETR:SAP – Get Rating) in a report issued on Tuesday, Borsen Zeitung reports.
Several other equities research analysts have also recently commented on SAP. Warburg Research set a €110.00 ($118.28) price objective on shares of SAP in a research report on Thursday, January 26th. Credit Suisse Group set a €120.00 ($129.03) price objective on shares of SAP in a research report on Wednesday, February 1st. Baader Bank set a €122.00 ($131.18) price objective on shares of SAP in a research report on Tuesday, January 31st. The Goldman Sachs Group set a €135.00 ($145.16) price objective on shares of SAP in a research report on Thursday, February 23rd. Finally, Jefferies Financial Group set a €100.00 ($107.53) price objective on shares of SAP in a research report on Monday.
SAP Trading Up 2.6 %
SAP opened at €110.06 ($118.34) on Tuesday. The stock has a market capitalization of $128.77 billion, a P/E ratio of 55.84, a P/E/G ratio of 1.43 and a beta of 1.00. SAP has a 12 month low of €79.58 ($85.57) and a 12 month high of €113.44 ($121.98). The firm’s fifty day simple moving average is €107.96 and its 200 day simple moving average is €99.03. The company has a current ratio of 1.06, a quick ratio of 0.92 and a debt-to-equity ratio of 28.37.
SAP Company Profile
SAP SE, together with its subsidiaries, operates as an enterprise application software company worldwide. The company operates through three segments: Applications, Technology & Support; Qualtrics; and Services. It offers SAP S/4HANA, an ERP suite with intelligent technologies, such as artificial intelligence, machine learning, and advanced analytics; SAP SuccessFactors Human Experience Management provides cloud-based solutions, such as a human resources management system for core HR and payroll, talent management, employee experience management, and people analytics; and intelligent spend management solutions, including products branded under the SAP Ariba, SAP Concur, and SAP Fieldglass names.
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for SAP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SAP and related companies with MarketBeat.com's FREE daily email newsletter.